Library
Lists
Topics
LibraryListsTopics
© 2026 Brad Roepke|About·Privacy·Terms·Disclaimer·Support
© 2026·About·Privacy·Terms·Disclaimer·Support
|

Do Massive Allograft Reconstructions for Tumors of the Femur and Tibia Survive 10 or More Years after Implantation?

·Clin Orthop Relat Res·2019·77 citations·Oncology
Free Full Text·DOI·PubMed
SummaryAbstract on PubMed →

This single-center retrospective study followed 198 patients who received massive segmental allografts (femur or tibia) after bone tumor resection, asking whether these reconstructions remain durable beyond 10 years. It is the largest series to report long-term complications and survivorship with minimum 10-year follow-up, with no patients lost to follow-up.

Study Snapshot

Design
Single-center retrospective cohort
Setting: Single center, Buenos Aires, Argentina
Objective
Whether massive segmental allografts survive 10 or more years after femoral or tibial tumor resection.
Outcome(s)
Freedom from allograft removal, joint replacement, or amputation at 5, 10, and 20 years
Subjects
198 patients
  • 132Femur
  • 66Tibia allografts
Inclusion
  • Segmental massive allograft for femur or tibia tumor
  • Benign or malignant primary bone tumor
  • Treated 1986–2007 at single center
Exclusion
  • Allograft-prosthetic composites (n=53)
  • Hemicondylar osteoarticular allografts (n=46)
  • Intercalary hemicylindrical allografts (n=57)
Follow-up
Mean 192 months overall; minimum 10 years for 166 survivors
Statistics
Competitive risk analysisMultivariate logistic regression

Key Findings

  • Overall allograft failure reached 40% at 10 years and 44% at 20 years — the slow rise after year 5 confirms late failure occurs, but infrequently. The plateau between years 10 and 20 supports counseling patients that a graft surviving a decade is relatively durable.
  • Osteoarticular proximal tibial allografts failed at a flat 58% across all time points (5, 10, and 20 years). Far worse than osteoarticular distal femoral allografts (30% at 10 years, p = 0.010) and tibial intercalary allografts (26%, p = 0.020). This is the number that drove the authors' practice change: proximal tibial osteoarticular allografts are now used only in pediatric patients.
  • Failure mode differs sharply by bone site:
    –Tibia: infection dominates (24% vs. 4% in femur, p < 0.001). Occurs mostly within the first 3 years
    –Femur: fracture dominates (18% vs. 5% in tibia, p < 0.010). Accumulates progressively over time, not front-loaded
    –This distinction drives surveillance strategy: watch the tibia early for infection, watch the femur indefinitely for fracture.
  • Among the 166 patients alive beyond 10 years, only 6 additional allografts were removed after the decade mark (4 fractures, 1 infection, 1 instability). A graft that survives year 10 is likely to survive further. But it is not guaranteed.
  • Malignant tumor resections carried significantly higher failure risk than benign resections at every time point (30% vs. 9% at 10 years, p = 0.008). Patients with benign tumors showed a flat 9% failure rate that did not increase over 20 years. Allografts perform much better in this population.
  • Patients with intact grafts at last follow-up achieved a mean MSTS score of 26/30, with 110 of 113 patients walking unaided. When a massive allograft survives, it delivers excellent functional outcomes. This is the argument for using it over endoprostheses in the right patient.
Board PearlProximal tibial osteoarticular allografts fail 58% of the time — nearly double distal femoral allografts — which is why this reconstruction is now reserved for pediatric patients only.

Clinical Relevance

Prior to this series, the accepted wisdom was that massive allograft complications cluster in the first 3 years — after that, the graft was considered stable. The authors provide the largest dataset with minimum 10-year follow-up to test that assumption directly.

When choosing between allograft and endoprosthesis for a young patient with a distal femoral osteosarcoma who responds to chemotherapy, an allograft is a reasonable option: the 10-year failure rate is 40%, but survivors function at MSTS 26/30 and walk unaided. For a proximal tibial tumor in an adult, the calculus is different. A 58% failure rate dominated by early infection makes this reconstruction hard to justify.

Counsel femoral allograft patients that fracture risk does not plateau: keep them under long-term surveillance and discuss the progressive fracture risk explicitly, especially for intercalary femoral reconstructions where the 20-year failure rate reaches 51%.

The authors themselves acknowledge they cannot directly compare allografts to endoprostheses in this dataset. The selection bias (higher-risk patients received prostheses) means these numbers represent a best-case allograft population.

Related Articles

Emerging

Do Massive Allograft Reconstructions for Tumors of the Femur and Tibia Survive 10 or More Years after Implantation?|

Aponte-Tinao, Farfalli, et al.·Clin Orthop Relat Res·2019·77 citations·Oncology
Landmark

Radiological Assessment of Osteo-Arthrosis.|

Kellgren, Lawrence·Ann Rheum Dis·1957·12,248 citations·General
Landmark

Mesenchymal Stem Cells.

Caplan·J Orthop Res·1991·6,470 citations·Basic Science
Landmark

Traumatic Arthritis of the Hip after Dislocation and Acetabular Fractures: Treatment by Mold Arthroplasty. an End-Result Study Using a New Method of Result Evaluation.

Harris·J Bone Joint Surg Am·1969·5,899 citations·Hip & Knee
Landmark

Bone: Formation by Autoinduction.

Urist·Science·1965·5,546 citations·Basic Science
Landmark

Treatment of Deep Cartilage Defects in the Knee with Autologous Chondrocyte Transplantation.|

Brittberg, Peterson, et al.·N Engl J Med·1994·5,478 citations·Sports Medicine
Landmark

Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity

Bohannon·Phys Ther·1987·5,350 citations·General
Landmark

Osteoclast Differentiation Factor Is a Ligand for Osteoprotegerin/osteoclastogenesis-Inhibitory Factor and Is Identical to Trance/rankl.|

Yasuda, Suda, et al.·Proc Natl Acad Sci U S A·1998·4,239 citations·Basic Science
Landmark

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis. Vigor Study Group.|

Bombardier, VIGOR Study Group, et al.·N Engl J Med·2000·4,036 citations·General
Landmark

Magnetic Resonance Classification of Lumbar Intervertebral Disc Degeneration.

Pfirrmann, Boos, et al.·Spine·2001·3,960 citations·Spine
Landmark

Novel Regulators of Bone Formation: Molecular Clones and Activities.

Wozney, Wang, et al.·Science·1988·3,906 citations·Basic Science
Landmark

The Diagnosis of Osteoporosis.

Kanis, Khaltaev, et al.·J Bone Miner Res·1994·3,840 citations·General
Landmark

"modes of Failure" of Cemented Stem-Type Femoral Components: a Radiographic Analysis of Loosening.

Gruen, Amstutz, et al.·Clin Orthop Relat Res·1979·3,647 citations·Hip & Knee
Landmark

Biomechanical Measures of Neuromuscular Control and Valgus Loading of the Knee Predict Anterior Cruciate Ligament Injury Risk in Female Athletes: a Prospective Study.

Hewett, Succop, et al.·Am J Sports Med·2005·3,495 citations·Sports Medicine
Landmark

Femoroacetabular Impingement: a Cause for Osteoarthritis of the Hip.

Ganz, Siebenrock, et al.·Clin Orthop Relat Res·2003·3,410 citations·Hip & Knee
Landmark

Prevention of Infection in the Treatment of One Thousand and Twenty-Five Open Fractures of Long Bones: Retrospective and Prospective Analyses.

Gustilo, Anderson·J Bone Joint Surg Am·1976·3,211 citations·Trauma
Landmark

The Variation in Isometric Tension with Sarcomere Length in Vertebrate Muscle Fibres.

Gordon, Julian, et al.·J Physiol·1966·3,135 citations·Basic Science
Landmark

Osteoarthritis: a Disease of the Joint as an Organ.|

Loeser, Goldring, et al.·Arthritis Rheum·2012·2,961 citations·Basic Science
Landmark

Radiological Demarcation of Cemented Sockets in Total Hip Replacement.

DeLee, Charnley·Clin Orthop Relat Res·1976·2,913 citations·Hip & Knee
Landmark

Ectopic Ossification Following Total Hip Replacement. Incidence and a Method of Classification.

Brooker, Riley, et al.·J Bone Joint Surg Am·1973·2,880 citations·Hip & Knee
Landmark

The Operation of the Century: Total Hip Replacement.

Learmonth, Rorabeck, et al.·Lancet·2007·2,788 citations·Hip & Knee
Landmark

Fatty Muscle Degeneration in Cuff Ruptures. Pre- and Postoperative Evaluation by CT Scan.

Goutallier, Voisin, et al.·Clin Orthop Relat Res·1994·2,669 citations·Shoulder & Elbow
Landmark

Osseointegrated Titanium Implants. Requirements for Ensuring a Long-Lasting, Direct Bone-To-Implant Anchorage in Man.

Albrektsson, Lindström, et al.·Acta Orthop Scand·1981·2,662 citations·Basic Science
Landmark

The Etiology of Chondromalacia Patellae.

Outerbridge·J Bone Joint Surg Br·1961·2,659 citations·Sports Medicine
Landmark

Fracture and Dislocation Classification Compendium-2018.

Meinberg, Kellam, et al.·J Orthop Trauma·2018·2,622 citations·Trauma
Landmark

The Three Column Spine and Its Significance in the Classification of Acute Thoracolumbar Spinal Injuries.

Denis·Spine·1983·2,566 citations·Spine
Landmark

Dislocations after Total Hip-Replacement Arthroplasties.

Lewinnek, Zimmerman, et al.·J Bone Joint Surg Am·1978·2,549 citations·Hip & Knee
Landmark

Patient Satisfaction after Total Knee Arthroplasty: Who Is Satisfied and Who Is Not?|

Bourne, Charron, et al.·Clin Orthop Relat Res·2010·2,475 citations·Hip & Knee
Landmark

Problems in the Management of Type III (severe) Open Fractures: a New Classification of Type III Open Fractures.

Gustilo, Williams, et al.·J Trauma·1984·2,361 citations·Trauma
Landmark

The Value of Postural Reduction in the Initial Management of Closed Injuries of the Spine with Paraplegia and Tetraplegia. I.

Frankel, Walsh, et al.·Paraplegia·1969·2,283 citations·Spine
Landmark

Vacuum-Assisted Closure: a New Method for Wound Control and Treatment: Animal Studies and Basic Foundation.

Morykwas, McGuirt, et al.·Ann Plast Surg·1997·2,218 citations·Basic Science
Landmark

A System for the Functional Evaluation of Reconstructive Procedures after Surgical Treatment of Tumors of the Musculoskeletal System.

Enneking, Pritchard, et al.·Clin Orthop Relat Res·1993·2,209 citations·Oncology
Landmark

A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee|

Moseley, Wray, et al.·N Engl J Med·2002·2,154 citations·Hip & Knee
Landmark

The Stabilizing System of the Spine. Part I. Function, Dysfunction, Adaptation, and Enhancement.

Panjabi·J Spinal Disord·1992·2,145 citations·Spine
Landmark

The Outcome and Repair Integrity of Completely Arthroscopically Repaired Large and Massive Rotator Cuff Tears.

Galatz, Yamaguchi, et al.·J Bone Joint Surg Am·2004·2,135 citations·Shoulder & Elbow
Landmark

The Tension-Stress Effect on the Genesis and Growth of Tissues. Part I. the Influence of Stability of Fixation and Soft-Tissue Preservation.

Ilizarov·Clin Orthop Relat Res·1989·2,120 citations·Basic Science
Landmark

A System for the Surgical Staging of Musculoskeletal Sarcoma.

Enneking, Goodman, et al.·Clin Orthop Relat Res·1980·2,112 citations·Oncology
Landmark

A Comprehensive Classification of Thoracic and Lumbar Injuries|Citation only

Magerl·Eur Spine J·1994·2,067 citations·Spine
Landmark

Effect of the Tyrosine Kinase Inhibitor Sti571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor|Citation only|

Joensuu·N Engl J Med·2001·2,056 citations·Oncology
Landmark

Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture.|

Lyles, HORIZON Recurrent Fracture Trial, et al.·N Engl J Med·2007·1,995 citations·Trauma
Landmark

Factors of Patellar Instability: an Anatomic Radiographic Study.

Dejour, Guier, et al.·Knee·1994·1,987 citations·Sports Medicine
Landmark

Displaced Proximal Humeral Fractures. I. Classification and Evaluation.

Neer·J Bone Joint Surg Am·1970·1,957 citations·Trauma
Landmark

Hip Morphology Influences the Pattern of Damage to the Acetabular Cartilage: Femoroacetabular Impingement as a Cause of Early Osteoarthritis of the Hip.|

Beck, Ganz, et al.·J Bone Joint Surg Br·2005·1,955 citations·Hip & Knee
Core

Porosity of 3D Biomaterial Scaffolds and Osteogenesis.

Karageorgiou, Kaplan·Biomaterials·2005·6,476 citations·Basic Science
Core

A Report: the Definition and Classification of Cerebral Palsy April 2006.

Rosenbaum, Jacobsson, et al.·Dev Med Child Neurol·2007·4,795 citations·Pediatrics
Core

Clinician's Guide to Prevention and Treatment of Osteoporosis.|

Cosman, National Osteoporosis Foundation, et al.·Osteoporos Int·2014·4,062 citations·General
Core

Prevention of Venous Thromboembolism|Citation only

Geerts·Chest·2008·3,825 citations·Hip & Knee
Core

The Development of Assessment of Spondyloarthritis International Society Classification Criteria for Axial Spondyloarthritis (part II): Validation and Final Selection|Citation only|

Rudwaleit·Ann Rheum Dis·2009·3,656 citations·Spine
Core

Radiation Exposure from CT Scans in Childhood and Subsequent Risk of Leukaemia and Brain Tumours: a Retrospective Cohort Study.|

Pearce, Berrington de González, et al.·Lancet·2012·3,643 citations·Pediatrics
Core

Epidemiology of Adult Fractures: a Review.

Court-Brown, Caesar·Injury·2006·3,607 citations·Trauma
Core

Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017.|

Berríos-Torres, Healthcare Infection Control Practices Advisory Committee, et al.·JAMA Surg·2017·3,442 citations·General
Core

Osteoblastic Cells Regulate the Haematopoietic Stem Cell Niche.|

Calvi, Scadden, et al.·Nature·2003·3,391 citations·Basic Science
Core

A Joint Coordinate System for the Clinical Description of Three-Dimensional Motions: Application to the Knee.

Grood, Suntay·J Biomech Eng·1983·3,309 citations·Basic Science
Core

Consensus Statement on Concussion in Sport-The 5th International Conference on Concussion in Sport Held in Berlin, October 2016.|

McCrory, Vos, et al.·Br J Sports Med·2017·3,303 citations·Sports Medicine
Core

Oarsi Guidelines for the Non-Surgical Management of Knee Osteoarthritis.|

McAlindon, Underwood, et al.·Osteoarthritis Cartilage·2014·3,129 citations·Hip & Knee
Core

Estimating the Prevalence of Limb Loss in the United States: 2005 to 2050.

Ziegler-Graham, Brookmeyer, et al.·Arch Phys Med Rehabil·2008·2,780 citations·General
Core

Metastasis to Bone: Causes, Consequences and Therapeutic Opportunities.

Mundy·Nat Rev Cancer·2002·2,765 citations·Oncology
Core

Role of Proinflammatory Cytokines in the Pathophysiology of Osteoarthritis.

Kapoor, Fahmi, et al.·Nat Rev Rheumatol·2011·2,711 citations·Basic Science
Core

The Basic Science of Articular Cartilage: Structure, Composition, and Function.|

Sophia Fox, Rodeo, et al.·Sports Health·2009·2,681 citations·Basic Science
Core

Osteoporosis: Now and the Future.|

Rachner, Hofbauer, et al.·Lancet·2011·2,604 citations·General
Core

Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity.

Coleman·Clin Cancer Res·2006·2,461 citations·Oncology
Core

Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs. a 1:1:2 Ratio and Mortality in Patients with Severe Trauma: the Proppr Randomized Clinical Trial

Holcomb, PROPPR Study Group, et al.·JAMA·2015·2,453 citations·Trauma
Core

Direct Decompressive Surgical Resection in the Treatment of Spinal Cord Compression Caused by Metastatic Cancer: a Randomised Trial.

Patchell, Young, et al.·Lancet·2005·2,356 citations·Spine
Core

Fracture and Dislocation Classification Compendium - 2007: Orthopaedic Trauma Association Classification, Database and Outcomes Committee.

Marsh, Audigé, et al.·J Orthop Trauma·2007·2,343 citations·Trauma
Core

Peek Biomaterials in Trauma, Orthopedic, and Spinal Implants.|

Kurtz, Devine·Biomaterials·2007·2,304 citations·Basic Science
Core

Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older|Citation only|

Dawson-Hughes·N Engl J Med·1997·2,295 citations·General
Core

The Long-Term Consequence of Anterior Cruciate Ligament and Meniscus Injuries: Osteoarthritis.|

Lohmander, Roos, et al.·Am J Sports Med·2007·2,251 citations·Sports Medicine
Core

Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America.|

Osmon, Infectious Diseases Society of America, et al.·Clin Infect Dis·2013·2,220 citations·Hip & Knee
Core

The Amazing Osteocyte.|

Bonewald·J Bone Miner Res·2011·2,169 citations·Basic Science
Core

Osteosarcoma Incidence and Survival Rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program.|

Mirabello, Savage, et al.·Cancer·2009·2,165 citations·Oncology
Core

Projected Volume of Primary Total Joint Arthroplasty in the U.s., 2014 to 2030.

Sloan, Sheth, et al.·J Bone Joint Surg Am·2018·2,092 citations·Hip & Knee
Core

The 2018 Definition of Periprosthetic Hip and Knee Infection: an Evidence-Based and Validated Criteria.

Parvizi, Shohat, et al.·J Arthroplasty·2018·2,065 citations·Hip & Knee
Core

Bone Quality--The Material and Structural Basis of Bone Strength and Fragility.

Seeman, Delmas·N Engl J Med·2006·2,052 citations·Basic Science
Core

Prevalence of Muscular Dystrophies: a Systematic Literature Review.|

Theadom, Feigin, et al.·Neuroepidemiology·2014·2,050 citations·Pediatrics
Core

Mechanisms of Bone Metastasis.

Roodman·Discov Med·2004·2,028 citations·Oncology
Core

The Compressive Behavior of Bone as a Two-Phase Porous Structure.

Carter, Hayes·J Bone Joint Surg Am·1977·1,998 citations·Basic Science
Core

Metastatic Bone Disease: Clinical Features, Pathophysiology and Treatment Strategies.

Coleman·Cancer Treat Rev·2001·1,927 citations·Oncology
Emerging

Diagnosis and Treatment of Hip and Knee Osteoarthritis|

Katz, Loeser, et al.·JAMA·2021·2,126 citations·Hip & Knee
Supplemental

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis.|

Cummings, FREEDOM Trial, et al.·N Engl J Med·2009·3,382 citations·General
Supplemental

Opgl Is a Key Regulator of Osteoclastogenesis, Lymphocyte Development and Lymph-Node Organogenesis.

Kong, Penninger, et al.·Nature·1999·3,356 citations·Basic Science
Supplemental

Osteoarthritis: New Insights. Part 1: the Disease and Its Risk Factors.

Felson, Fries, et al.·Ann Intern Med·2000·2,525 citations·Hip & Knee
Supplemental

Morbidity at Bone Graft Donor Sites.

Younger, Chapman·J Orthop Trauma·1989·2,008 citations·General
Supplemental

Articular Cartilage Repair: Basic Science and Clinical Progress. a Review of the Current Status and Prospects.

Hunziker·Osteoarthritis Cartilage·2002·1,954 citations·Basic Science
Reference

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors.

Takahashi, Yamanaka, et al.·Cell·2007·20,127 citations·Basic Science
Reference

Guidelines for the Process of Cross-Cultural Adaptation of Self-Report Measures|Citation only

Beaton·Spine·2000·14,242 citations·General
Reference

Assessment of Coma and Impaired Consciousness. a Practical Scale.

Teasdale, Jennett·Lancet·1974·13,082 citations·Trauma
Reference

Development and Reliability of a System to Classify Gross Motor Function in Children with Cerebral Palsy

Palisano, Galuppi, et al.·Dev Med Child Neurol·1997·8,546 citations·Pediatrics
Reference

Validation Study of Womac: a Health Status Instrument for Measuring Clinically Important Patient Relevant Outcomes to Antirheumatic Drug Therapy in Patients with Osteoarthritis of the Hip or Knee.

Bellamy, Stitt, et al.·The Journal of rheumatology·1988·7,828 citations·Hip & Knee
Reference

Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030.

Kurtz, Halpern, et al.·J Bone Joint Surg Am·2007·7,476 citations·Hip & Knee
Reference

The Oswestry Disability Index.

Fairbank, Pynsent·Spine·2000·5,651 citations·Spine
Reference

A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population.|

Haynes, Safe Surgery Saves Lives Study Group, et al.·N Engl J Med·2009·5,579 citations·General
Reference

A Clinical Method of Functional Assessment of the Shoulder.

Constant, Murley·Clin Orthop Relat Res·1987·5,271 citations·Shoulder & Elbow
Reference

Rating Systems in the Evaluation of Knee Ligament Injuries.

Tegner, Lysholm·Clin Orthop Relat Res·1985·4,572 citations·Sports Medicine
Reference

Sf-36 Health Survey Update|Citation only

Ware·Spine·2000·4,490 citations·General
Reference

Rationale of the Knee Society Clinical Rating System.

Insall, Scott, et al.·Clin Orthop Relat Res·1989·4,195 citations·Hip & Knee
Reference

Knee Injury and Osteoarthritis Outcome Score (koos)--Development of a Self-Administered Outcome Measure.

Roos, Beynnon, et al.·J Orthop Sports Phys Ther·1998·3,837 citations·Sports Medicine
Reference

Evaluation of Knee Ligament Surgery Results with Special Emphasis on Use of a Scoring Scale.

Lysholm, Gillquist·Am J Sports Med·1982·2,762 citations·Sports Medicine
Reference

Development and Validation of the International Knee Documentation Committee Subjective Knee Form.

Irrgang, Shelborne, et al.·Am J Sports Med·2001·2,141 citations·Sports Medicine
Reference

Delirium in Older Persons.|Citation only|

Inouye·N Engl J Med·2006·2,082 citations·General
Reference

Calcium Phosphate Ceramics as Hard Tissue Prosthetics.

Jarcho·Clin Orthop Relat Res·1981·2,003 citations·Basic Science
Reference

The Knee Society Total Knee Arthroplasty Roentgenographic Evaluation and Scoring System.

Ewald·Clin Orthop Relat Res·1989·1,948 citations·Hip & Knee
|

Do Massive Allograft Reconstructions for Tumors of the Femur and Tibia Survive 10 or More Years after Implantation?

·Clin Orthop Relat Res·2019·77 citations·Oncology
Free Full Text·DOI·PubMed
SummaryAbstract on PubMed →

This single-center retrospective study followed 198 patients who received massive segmental allografts (femur or tibia) after bone tumor resection, asking whether these reconstructions remain durable beyond 10 years. It is the largest series to report long-term complications and survivorship with minimum 10-year follow-up, with no patients lost to follow-up.

Study Snapshot

Design
Single-center retrospective cohort
Setting: Single center, Buenos Aires, Argentina
Objective
Whether massive segmental allografts survive 10 or more years after femoral or tibial tumor resection.
Outcome(s)
Freedom from allograft removal, joint replacement, or amputation at 5, 10, and 20 years
Subjects
198 patients
  • 132Femur
  • 66Tibia allografts
Inclusion
  • Segmental massive allograft for femur or tibia tumor
  • Benign or malignant primary bone tumor
  • Treated 1986–2007 at single center
Exclusion
  • Allograft-prosthetic composites (n=53)
  • Hemicondylar osteoarticular allografts (n=46)
  • Intercalary hemicylindrical allografts (n=57)
Follow-up
Mean 192 months overall; minimum 10 years for 166 survivors
Statistics
Competitive risk analysisMultivariate logistic regression

Key Findings

  • Overall allograft failure reached 40% at 10 years and 44% at 20 years — the slow rise after year 5 confirms late failure occurs, but infrequently. The plateau between years 10 and 20 supports counseling patients that a graft surviving a decade is relatively durable.
  • Osteoarticular proximal tibial allografts failed at a flat 58% across all time points (5, 10, and 20 years). Far worse than osteoarticular distal femoral allografts (30% at 10 years, p = 0.010) and tibial intercalary allografts (26%, p = 0.020). This is the number that drove the authors' practice change: proximal tibial osteoarticular allografts are now used only in pediatric patients.
  • Failure mode differs sharply by bone site:
    –Tibia: infection dominates (24% vs. 4% in femur, p < 0.001). Occurs mostly within the first 3 years
    –Femur: fracture dominates (18% vs. 5% in tibia, p < 0.010). Accumulates progressively over time, not front-loaded
    –This distinction drives surveillance strategy: watch the tibia early for infection, watch the femur indefinitely for fracture.
  • Among the 166 patients alive beyond 10 years, only 6 additional allografts were removed after the decade mark (4 fractures, 1 infection, 1 instability). A graft that survives year 10 is likely to survive further. But it is not guaranteed.
  • Malignant tumor resections carried significantly higher failure risk than benign resections at every time point (30% vs. 9% at 10 years, p = 0.008). Patients with benign tumors showed a flat 9% failure rate that did not increase over 20 years. Allografts perform much better in this population.
  • Patients with intact grafts at last follow-up achieved a mean MSTS score of 26/30, with 110 of 113 patients walking unaided. When a massive allograft survives, it delivers excellent functional outcomes. This is the argument for using it over endoprostheses in the right patient.
Board PearlProximal tibial osteoarticular allografts fail 58% of the time — nearly double distal femoral allografts — which is why this reconstruction is now reserved for pediatric patients only.

Clinical Relevance

Prior to this series, the accepted wisdom was that massive allograft complications cluster in the first 3 years — after that, the graft was considered stable. The authors provide the largest dataset with minimum 10-year follow-up to test that assumption directly.

When choosing between allograft and endoprosthesis for a young patient with a distal femoral osteosarcoma who responds to chemotherapy, an allograft is a reasonable option: the 10-year failure rate is 40%, but survivors function at MSTS 26/30 and walk unaided. For a proximal tibial tumor in an adult, the calculus is different. A 58% failure rate dominated by early infection makes this reconstruction hard to justify.

Counsel femoral allograft patients that fracture risk does not plateau: keep them under long-term surveillance and discuss the progressive fracture risk explicitly, especially for intercalary femoral reconstructions where the 20-year failure rate reaches 51%.

The authors themselves acknowledge they cannot directly compare allografts to endoprostheses in this dataset. The selection bias (higher-risk patients received prostheses) means these numbers represent a best-case allograft population.

Related Articles